Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas Journal Article


Author: Hensley, M. L.
Article Title: Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas
Abstract: Uterine sarcomas are rare, high-risk malignancies. Expert histologic review is important for accurate diagnosis. For high-grade leiomyosarcomas, the risk of recurrence is high after complete resection of uterus-limited disease; however, no adjuvant therapy has been proven to improve survival. Chemotherapy regimens with efficacy in treating advanced uterine leiomyosarcoma include gemcitabine-docetaxel, doxorubicin and ifosfamide. Uterine carcinosarcomas also carry a high risk of recurrence. Adjuvant chemotherapy is a standard approach for completely resected and metastatic carcinosarcoma. Active agents include carboplatin, cisplatin, ifosfamide and paclitaxel. © 2011 Elsevier Ltd. All rights reserved.
Keywords: treatment outcome; treatment response; survival rate; overall survival; thalidomide; fatigue; neutropenia; review; cancer recurrence; sorafenib; bevacizumab; cisplatin; doxorubicin; sunitinib; advanced cancer; cancer combination chemotherapy; drug efficacy; skin toxicity; gemcitabine; paclitaxel; cancer adjuvant therapy; cancer radiotherapy; chemotherapy; temozolomide; topotecan; drug megadose; imatinib; carboplatin; dacarbazine; unindexed drug; multiple cycle treatment; etoposide; bleeding; cyclophosphamide; continuous infusion; ifosfamide; docetaxel; exemestane; protein tyrosine kinase inhibitor; pneumothorax; cardiotoxicity; mitoxantrone; pazopanib; soft tissue sarcoma; sepsis; letrozole; intestine perforation; trabectedin; leiomyosarcoma; estrogen receptor; progesterone receptor; anastrozole; alopecia; wound dehiscence; uterine leiomyosarcoma; uterus sarcoma; liposarcoma; carcinosarcoma; randomized controlled trial (topic); megestrol; trimetrexate; high undifferentiated sarcoma; piperazinedione
Journal Title: Best Practice and Research: Clinical Obstetrics and Gynaecology
Volume: 25
Issue: 6
ISSN: 1521-6934
Publisher: Elsevier Inc.  
Date Published: 2011-12-01
Start Page: 773
End Page: 782
Language: English
DOI: 10.1016/j.bpobgyn.2011.06.003
PROVIDER: scopus
PUBMED: 21752717
DOI/URL:
Notes: --- - "Export Date: 9 December 2011" - "CODEN: BPRCF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martee L Hensley
    290 Hensley